Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses

Archives of Virology

Volumn 143, Issue 5, 1998, Pages 997-1003

  Porter, K R ^a,b,c   Kochel, T J ^a   Wu, S J ^a   Raviprakash, K ^a   Phillips, I ^a   Hayes, C G ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c Unit 8132 NAMRU TWO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; DENGUE VIRUS; DNA VACCINE; MOUSE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CPG ISLANDS; DENGUE; DENGUE VIRUS; FEMALE; MICE; MICE, INBRED BALB C; VACCINES, DNA; VIRAL VACCINES;

ANIMALIA; DENGUE VIRUS;

EID: 0031862714     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050348     Document Type: Article

References (14)

1. Ansari M, Shope R, Malik S (1993) Evaluation of Vero cell lysate antigen for the ELISA of flaviviruses. J Clin Lab 7: 230-237
2. Babiuk LA, Lewis PJ, Cox G, van Drunen Littel van den Hurk S, Baca Estrade M, Tikoo SK (1995) DNA immunization with bovine herpesvirus-1 genes. Ann N Y Acad Sci 772: 47-63
3. Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB (1997) Protection of chimpanzees from high-dose heterologous HIV-I challenge by DNA vaccination. Nature Med 3: 526-532
4. Cole GA, Wisseman CL Jr (1969) Pathogenesis of type 1 dengue virus infection in suckling, weanling and adult mice. 1. The relation of virus replication to interferon and antibody formation. Am J Epidemiol 89: 669-680
5. Davis HL, McCluskie MJ, Gerin JL, Purcell RH (1996) DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci USA 93: 7213-7218
6. Donnelly JJ, Friedman A, Martinez D, Montgomery DL, Shiver JW, Motzel SL, Ulmer JB, Liu MA (1995) Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nature Med 1: 583-587
7. Edelman R, Tacket CO, Wasserman SS, Vaughn DW, Eckels KH, Dubois DR, Summers PL, Hoke CH (1994) A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dig kidney cell culture is attenuated and immunogenic for humans. J Infect Dis 170: 1448-1455
8. Hoffman SL, Doolan DL, Sedegah M, Gramzinski R, Wang H, Gowda K, Hobart P, Margalith M, Norman J, Hedstrom RC (1995) Nucleic acid malaria vaccines. Current status and potential. Ann N Y Acad Sci 772: 88-94
9. Klinman DM, Yamshchikov G, Ishigatsubo Y (1997) Contribution of CpG Motifs to the Immunogenicity of DNA Vaccines. J Immunol 158: 3635-3639
10. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM (1996) CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 93: 2879-2883
11. Kochel T, Wu S-J, Raviprakash K, Hobart P, Hoffman S, Porter K, Hayes C (1997) Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine 15: 547-552
12. Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yankauckas MA, Baird SM, Rhodes GH (1994) Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 91:9519-9523
13. Russel P, Nisalak A (1967) Dengue virus identification by the plaque reduction neutralization test. J Immunol 99: 291-296
14. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA, Raz E (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352-354